Title | Hybrid Learning in the PharmD Program (HIPP) |
---|---|
Faculty/College/Unit | Pharmaceutical Sciences |
Status | Active |
Duration | 2 Year |
Initiation | 04/01/2023 |
Project Summary | A comprehensive evaluation of online modalities used during the pandemic yielded important guiding principles for the Entry-to-Practice PharmD Program revision, particularly greater adoption of hybrid curriculum delivery using innovative online and in-person activities. This project aims to develop and implement asynchronous learning activities as core components of hybrid delivery throughout the Program. The asynchronous learning activities will (1) support learner flexibility and autonomy; (2) use Universal Design for Learning principles and accessibility standards; (3) align with curricular objectives. In project Year 1 (HIPP-Y1), three prototypes of asynchronous learning activities will be developed, piloted and evaluated. In HIPP-Y2, the original prototypes will be modified based on evaluation results, and a minimum of six additional learning activities will be deployed, along with documentation and templates for development beyond the project period. HIPP will inform hybrid learning best practices as the program undertakes a curriculum renewal occurring in a separate but parallel process. |
Funding Details | |
Year 1: Project Year | Year 1 |
Year 1: Funding Year | 2023/2024 |
Year 1: Project Type | Large TLEF |
Year 1: Principal Investigator | Kerry Wilbur |
Year 1: Funded Amount | 71,817 |
Year 1: Team Members | Principal Applicants: Kerry Wilbur, Associate Professor / Executive Director, Entry-to-Practice (E2P) PharmD Program, Faculty of Pharmaceutical Sciences Students: Jasmin Kaur Gill, PY4 E2P PharmD Student Faculty Leadership: Marion Pearson, Professor of Teaching, Faculty of Pharmaceutical Sciences Program Staff: Leah Villalobos, Program Manager, E2P PharmD, Faculty of Pharmaceutical Sciences Enabling Unit Faculty and Staff: George Pachev, Lecturer / Director, Office of Educational Assessment (OEA), Faculty of Pharmaceutical Sciences |